Molbio Diagnostics Limited (NSE:MOLBIO)

Molbio Diagnostics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Cash & Equivalents	3,555	1,147	221.1	69.75
Short-Term Investments	150.87	143.06	1.09	2.64
Cash & Short-Term Investments	3,706	1,291	222.19	72.39
Cash Growth	187.18%	480.83%	206.94%	-
Accounts Receivable	4,097	2,717	4,254	1,888
Other Receivables	163.22	49.39	75.01	110.22
Receivables	4,261	2,766	4,329	1,998
Inventory	4,493	4,359	3,151	3,470
Prepaid Expenses	23.5	17.62	8.07	6.12
Other Current Assets	1,366	865.04	520.44	620.99
Total Current Assets	13,848	9,298	8,232	6,167
Property, Plant & Equipment	3,148	2,602	1,837	1,965
Long-Term Investments	351.31	507.8	59.86	60.05
Goodwill	621.28	38.41	38.41	38.41
Other Intangible Assets	1,708	527.8	704.16	912.38
Long-Term Accounts Receivable	1.13	-	-	-
Long-Term Deferred Tax Assets	515.53	469.43	291.12	104.42
Other Long-Term Assets	1,291	1,078	1,048	1,072
Total Assets	21,484	14,616	12,211	10,342

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Accounts Payable	1,995	2,302	939.88	855.22
Accrued Expenses	479.51	344.13	505.15	325.53
Short-Term Debt	1,802	1,058	1,490	1,057
Current Portion of Long-Term Debt	200.04	112.65	104.54	17.16
Current Portion of Leases	102.35	63.55	44.14	32.46
Current Unearned Revenue	159.82	60.68	73.22	94.45
Other Current Liabilities	834.57	475.98	270.7	193.28
Total Current Liabilities	5,574	4,417	3,428	2,575
Long-Term Debt	2,124	61.44	151.23	9.85
Long-Term Leases	272.03	174.14	46.34	68.51
Pension & Post-Retirement Benefits	95.66	40.53	18.96	15.28
Long-Term Deferred Tax Liabilities	331.14	2.94	31.03	52.59
Other Long-Term Liabilities	-	247	247	247
Total Liabilities	8,396	4,943	3,922	2,969

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Common Stock	112.76	22.56	22.54	22.54
Additional Paid-In Capital	1,959	1,959	1,949	1,949
Retained Earnings	9,227	7,647	6,203	5,184
Comprehensive Income & Other	395.35	56.17	59.67	59.67
Total Common Equity	11,693	9,684	8,234	7,215
Minority Interest	1,394	-11.06	54.56	158.62
Shareholders' Equity	13,088	9,673	8,288	7,373
Total Liabilities & Equity	21,484	14,616	12,211	10,342

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023
Total Debt	4,501	1,469	1,836	1,185
Net Cash (Debt)	-794.59	-178.78	-1,614	-1,113
Net Cash Growth	-	-	-	-
Net Cash Per Share	-7.05	-1.59	-14.31	-9.89
Filing Date Shares Outstanding	112.76	112.8	112.68	112.51
Total Common Shares Outstanding	112.76	112.8	112.68	112.51
Working Capital	8,275	4,882	4,804	3,592
Book Value Per Share	103.70	85.85	73.07	64.13
Tangible Book Value	9,364	9,118	7,491	6,264
Tangible Book Value Per Share	83.04	80.83	66.48	55.68
Land	329.69	329.69	-	-
Buildings	755.42	595.22	595.22	593.77
Machinery	2,829	2,271	2,010	1,894
Construction In Progress	113.21	273.31	15.83	-
Leasehold Improvements	57.87	2.7	2.6	2.6

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every year for this company.

Update frequency:

Yearly

Last checked:

Aug 26, 2026

Data Sources Report a data error